The emergence of cannabinoid hyperemesis syndrome

Abstract

Cannabinoid hyperemesis syndrome (CHS), characterized by severe abdominal pain and significant cyclical nausea and vomiting, is an emerging condition that's often not diagnosed properly due to lack of knowledge and the underreporting of cannabis use by patients. Proper diagnosis and assessment of CHS can lead to quicker diagnosis and treatment, as well as decrease unnecessary, costly testing and procedures. This article provides the latest information on CHS, including nursing implications and future considerations.